HK1200502A1 - 判定患者前列腺癌預測的方法 - Google Patents

判定患者前列腺癌預測的方法

Info

Publication number
HK1200502A1
HK1200502A1 HK15101066.0A HK15101066A HK1200502A1 HK 1200502 A1 HK1200502 A1 HK 1200502A1 HK 15101066 A HK15101066 A HK 15101066A HK 1200502 A1 HK1200502 A1 HK 1200502A1
Authority
HK
Hong Kong
Prior art keywords
subject
prostate cancer
determining prognosis
prognosis
determining
Prior art date
Application number
HK15101066.0A
Other languages
English (en)
Inventor
Attila Lorincz
Natasa Vasiljevic
Amar Ahmad
Original Assignee
Univ London Queen Mary
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London Queen Mary filed Critical Univ London Queen Mary
Publication of HK1200502A1 publication Critical patent/HK1200502A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK15101066.0A 2012-03-19 2015-01-30 判定患者前列腺癌預測的方法 HK1200502A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1204785.8A GB201204785D0 (en) 2012-03-19 2012-03-19 Method for determining prognosis of prostate cancer in a subject
PCT/GB2013/050714 WO2013140161A1 (en) 2012-03-19 2013-03-19 Method for determining prognosis of prostate cancer in a subject

Publications (1)

Publication Number Publication Date
HK1200502A1 true HK1200502A1 (zh) 2015-08-07

Family

ID=46052156

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15101066.0A HK1200502A1 (zh) 2012-03-19 2015-01-30 判定患者前列腺癌預測的方法

Country Status (5)

Country Link
US (1) US9845506B2 (zh)
EP (1) EP2828404B1 (zh)
GB (1) GB201204785D0 (zh)
HK (1) HK1200502A1 (zh)
WO (1) WO2013140161A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113215260A (zh) * 2021-06-18 2021-08-06 杭州昱鼎生物科技有限公司 一种gstp1，apc和rassf1在制备前列腺癌标志物中的应用及其试剂盒

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11685955B2 (en) 2016-05-16 2023-06-27 Dimo Dietrich Method for predicting response of patients with malignant diseases to immunotherapy
DE102016005947B3 (de) 2016-05-16 2017-06-08 Dimo Dietrich Verfahren zur Abschätzung der Prognose und zur Prädiktion des Ansprechens auf eine Immuntherapie von Patienten mit malignen Erkrankungen
GB201816820D0 (en) 2018-10-16 2018-11-28 Univ York Diagnostic method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
DK1545561T3 (da) 2002-10-02 2010-08-02 Univ British Columbia Oligonucleotider til behandling af prostata og andre cancersygdomme
JP2007513621A (ja) * 2003-12-11 2007-05-31 エピゲノミクス アーゲー 乳房細胞増殖性障害の改良された処置のための方法および核酸
GB0504302D0 (en) 2005-03-02 2005-04-06 Univ Dublin Markers for melanoma
ES2595208T3 (es) 2011-06-09 2016-12-28 Universidad De Valladolid Biopolímero termosensible y bioactivo y método de recolección celular asociado

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113215260A (zh) * 2021-06-18 2021-08-06 杭州昱鼎生物科技有限公司 一种gstp1，apc和rassf1在制备前列腺癌标志物中的应用及其试剂盒

Also Published As

Publication number Publication date
US9845506B2 (en) 2017-12-19
GB201204785D0 (en) 2012-05-02
US20150051084A1 (en) 2015-02-19
EP2828404A1 (en) 2015-01-28
WO2013140161A1 (en) 2013-09-26
EP2828404B1 (en) 2018-01-10

Similar Documents

Publication Publication Date Title
IL276488B (en) A method for predicting breast cancer prognosis
EP2847593A4 (en) METHODS FOR PREDICTING AND DETECTING THE RISK OF CANCER
EP2825674A4 (en) BIOMARKER FOR THYROID CANCER
EP2741085A4 (en) METHOD OF DETECTING PANCREATIC CANCER
ZA201400089B (en) Methods and nucleic acids for determining the prognosis of a cancer subject
EP2585833A4 (en) METHODS OF DETECTING CANCER
SG11201502778TA (en) Method of prognosis and stratification of ovarian cancer
HK1213297A1 (zh) 用於檢測和測定前列腺癌預後的組合物和方法
SG11201510210XA (en) Methods for detecting prostate cancer
EP2698634A4 (en) BIOMARKER FOR BREAST CANCER
EP2876447A4 (en) METHOD OF DETECTING CANCER
EP2876446A4 (en) METHOD OF DETECTING CANCER
EP2686447A4 (en) PROGNOSTIC MARKER SETS FOR PROSTATE CANCER
IL228636A0 (en) Biomarkers for predicting sensitivity to cancer treatments
EP2707721A4 (en) BIOMARKERS PREDICTIVE FOR PROSTATE CANCER
HK1200502A1 (zh) 判定患者前列腺癌預測的方法
EP2894477A4 (en) METHOD FOR DETECTION OF BREAST CANCER
PL2904398T3 (pl) Sposób przewidywania ryzyka zachorowania na raka u osobnika żeńskiego
EP2771695A4 (en) METHOD OF DETECTION OF BREAST CANCERS
EP2594943A4 (en) METHOD FOR DETECTING POOR TUMOR CELLS
EP2840147A4 (en) METHOD FOR ESTIMATING CANCER SUSCEPTIBILITY OF ENDOMETER
AU2013902141A0 (en) Method for detecting prostate cancer
GB201218219D0 (en) Nucleic acid biomarkers for prostate cancer
EP2707011A4 (en) METHOD FOR THE TREATMENT OF PROSTATE CANCER
GB201104205D0 (en) F56 biomarkers for prostate cancer